The present invention relates to crosslinked aliphatic polyesters and, more particularly, in certain embodiments, to methods and compositions that use crosslinked aliphatic polyesters in well bore applications, particularly in high-temperature applications.
Aliphatic polyesters are commonly employed in well bore applications. For instance, aliphatic polyesters may be used in subterranean operations as fluid loss control particles, diverting agents, bridging agents, drilling fluid additives, cement additives, and the like. In another instance, the aliphatic polyesters may be capable of releasing a desirable degradation product, e.g., an acid, during its hydrolysis. The acid released by certain aliphatic polyesters may be used to facilitate a reduction in viscosity of a fluid or to degrade a filter cake, as well as for numerous other functions in subterranean operations.
Inclusion of an aliphatic polyester capable of releasing an acid in a gelled (and optionally crosslinked) treatment fluid may be used to facilitate a reduction in viscosity of such fluid. Generally, these aliphatic polyesters likely will hydrolyze over time due to contact with water present in the fluid, thereby releasing an acid. Upon its hydrolysis, the acid will function, inter alia, to reduce the crosslinks in the treatment fluid, reducing the pH of the treatment fluid sufficiently to reverse the crosslinks therein, and/or breaking down the backbone of the gelling agent present in the treatment fluid. Typically, the acid released by the aliphatic polyester may breakdown the gelling agents, and this phenomena may be accelerated at elevated temperatures such as those above about 150° F.
Aliphatic polyesters capable of releasing an acid may also be used in the degradation of acid-soluble materials present in a subterranean formation, such as those present in or adjacent to filter cakes. Filter cakes commonly may be formed by a fluid (e.g., a treatment fluid) on the face of a portion of a subterranean formation, inter alia, to minimize damage to the permeability thereof. The filter cake often comprises an acid-soluble component (e.g., a calcium carbonate bridging agent) and a polymeric component (e.g., starch and xanthan). Before desirable fluids, such as hydrocarbons, may be produced, the filter cake is generally removed. To facilitate the degradation of the acid-soluble component, an aliphatic polyester capable of releasing an acid may be utilized. Filter cakes also may be removed using an acid where the filter cake does not contain an acid-soluble component, for example, by degrading the underlying carbonate adjacent to the filter cake, if the filter cake is present in a carbonate formation.
In one instance, the filter cake may be contacted by a treatment fluid that comprises the aliphatic polyester. The resultant acid should interact with the acid-soluble component of the filter cake and/or the underlying carbonate adjacent to the filter cake in such a way as to facilitate their degradation. In another instance, the aliphatic polyester capable of releasing an acid may be included in the fluid (such as the treatment fluid) that forms the filter cake, such that the filter cake further contains the aliphatic polyester. Subsequent contact of the filter cake with an aqueous fluid hydrolyzes the water-hydrolysable material thereby releasing an acid that acts to degrade the acid soluble component of the filter cake. Among other components, the aqueous fluid may contain oxidizing agents or enzymes suitable to facilitate the degradation of the polymeric component of the filter cake.
The use of aliphatic polyesters may be problematic in high-temperature wells. At higher temperatures, such as those above about 300° F., the use of aliphatic polyesters in subterranean formations may not be suitable. At such temperatures, the presence of aqueous fluids could lead to early hydrolysis of the aliphatic polyesters. Similarly the use of crystalline aliphatic polyesters or stereoisomers may also be problematic in high-temperature wells.
The present invention relates to crosslinked aliphatic polyesters and, more particularly, in certain embodiments, to methods and compositions that use crosslinked aliphatic polyesters in well bore applications, particularly in high-temperature applications.
In one embodiment, the present invention comprises a method comprising: providing a treatment fluid comprising a carrier fluid and a solid particle comprising a crosslinked aliphatic polyester; and placing the treatment fluid into a subterranean formation.
In another embodiment, the present invention comprises a method comprising: placing a treatment fluid in a subterranean formation, the treatment fluid comprising: a carrier fluid; a viscosifier; a fluid loss control additive; and a bridging agent comprising a crosslinked aliphatic polyester; and forming a filter cake comprising the bridging agent upon a surface within the subterranean formation whereby fluid loss to the subterranean formation through the filter cake is reduced.
In another embodiment, the present invention comprises a treatment fluid comprising a carrier fluid and a solid particle comprising a crosslinked aliphatic polyester.
The features and advantages of the present invention will be readily apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.
The present invention relates to crosslinked aliphatic polyesters and, more particularly, in certain embodiments, to methods and compositions that use crosslinked aliphatic polyesters in well bore applications, particularly in high-temperature applications.
There may be several potential advantages to the methods and compositions of the present invention. One of the many potential advantages of the methods and compositions of the present invention is that they may allow for, inter alia, higher temperature use in subterranean formations than methods and compositions that use uncrosslinked aliphatic polyesters. Another potential advantage of the methods and compositions of the present invention is that they may allow use in subterranean formations where longer degradation times are needed at higher temperatures, such as for use as diverting particles, filter cakes, fluid loss control additives, drill in fluids, or bridging agents. Methods of treating subterranean formations are described in U.S. Patent Application Publication Nos. 2007/0078064, 2005/0059556, and 2005/0059557, the entireties of which are herein incorporated by reference. Another potential advantage of the methods and compositions of the present invention is that crosslinking may also increase the heat stability of polyesters above the Tg and also increase the melting point of the polymer. In some instances it may be desirable for the polyesters to retain some of their solid particle properties past the Tg, Tc, or Tm of the aliphatic polyester.
Embodiments of the treatment fluids of the present invention generally comprise a carrier fluid and a solid particle comprising a crosslinked aliphatic polyester. The carrier fluid utilized in embodiments of the treatment fluids of the present invention may be aqueous-based, nonaqueous-based, or mixtures thereof. Where the carrier fluid is aqueous-based, the water used may be fresh water, salt water (e.g., water containing one or more salts dissolved therein), brine (e.g., saturated salt water), or seawater. Generally, the water may be from any source, provided that it does not contain an excess of compounds that may adversely affect other components in the treatment fluid. Where the carrier fluid is nonaqueous-based, the carrier fluid may comprise any number of organic fluids. Examples of suitable organic fluids include, but are not limited to, mineral oils, synthetic oils, esters and the like. These organic fluids may be referred to generically as “oils.” Generally, any oil in which a water solution of salts can be emulsified may be suitable for use as a carrier fluid in the treatment fluids of the present invention. Generally, the carrier fluid may be present in embodiments of the treatment fluids of the present invention in an amount in the range of about 20% to about 99% by weight of the treatment fluid. In certain embodiments, the carrier fluid may be present in the treatment fluids of the present invention in an amount in the range of about 20% to about 80% by weight of the treatment fluid.
The solid particle that comprises the crosslinked aliphatic polyester may be included in the treatment fluids of the present invention in an amount sufficient for a particular application. In certain embodiments, the solid particle may be present in an amount in the range of about 0.1% to about 32% by weight of the treatment fluid. In certain embodiments, the solid particle may be present in an amount of about 1% to about 10% by weight of the treatment fluid.
The specific features of the solid particle may be modified based on the particular application. For example, where used in forming a filter cake, the specific features of the solid particle may be modified so as to maintain the filter cake's filtering capability when the filter cake is intact while easing the removal of the filter cake when such removal becomes desirable. In certain embodiments, the solid particle may have a particle size distribution in the range of about 0.1 micron to about 1.0 millimeters. Furthermore, the solid particle may have any suitable shape, including, but not limited to, particles having the physical shape of platelets, shavings, flakes, ribbons, rods, strips, spheroids, toroids, pellets, tablets, or any other physical shape. One of ordinary skill in the art with the benefit of this disclosure will recognize the appropriate size and shape for a given application.
As previously mentioned, the solid particles included in embodiments of the treatment fluids may comprise a crosslinked aliphatic polyester. Suitable crosslinked aliphatic polyesters for use in embodiments of the present invention include those formed by crosslinking aliphatic polyesters having the general formula of repeating units shown below:
where n is an integer between 75 and 10,000 and R is a hydrogen, alkyl, aryl, alkylaryl, acetyl, heteroatoms, or mixtures thereof. Of these aliphatic polyesters, poly(lactic acid) is preferred. Poly(lactic acid) is synthesized either from lactic acid by a condensation reaction or more commonly by ring-opening polymerization of a cyclic lactide monomer. Since both lactic acid and lactide can achieve the same repeating unit, the general term poly(lactic acid), as used herein, refers to Formula I without any limitation as to how the polymer was made, such as from lactides, lactic acid, or oligomers, and without reference to the degree of polymerization or level of plasticization. The lactide monomer exists generally in three different forms: two stereoisomers L- and D-lactide and racemic D,L-lactide (meso-lactide). The oligomers of lactic acid and oligomers of lactide are defined by the formula:
where m is an integer 2≦m≦75. Preferably m is an integer and 2≦m≦10. These limits correspond to number average molecular weights below about 5,400 and below about 720, respectively. The chirality of the lactide units provides a means to adjust, inter alia, degradation rates, as well as physical and mechanical properties. Poly(L-lactide), for instance, is a semicrystalline polymer with a relatively slow hydrolysis rate. The use of poly(L-lactide) could be desirable in applications of the present invention where a slower degradation of the degradable particulates is desired. Poly(D,L-lactide) may be a more amorphous polymer with a resultant faster hydrolysis rate. The use of poly(D,L-lactide) may be suitable for other applications where a more rapid degradation may be appropriate. The stereoisomers of lactic acid may be used individually or combined to be used in accordance with embodiments of the present invention. Additionally, they may be copolymerized with, for example, glycolide or other monomers like ε-caprolactone, 1,5-dioxepan-2-one, trimethylene carbonate, or other suitable monomers to obtain polymers with different properties or degradation times. Additionally, the lactic acid stereoisomers can be modified to be used in embodiments of the present invention by, inter alia, blending, copolymerizing or otherwise mixing the stereoisomers, blending, copolymerizing or otherwise mixing high and low molecular weight poly(lactides), or by blending, copolymerizing or otherwise mixing a poly(lactic acid) with another polyester or polyesters.
Plasticizers may be used in embodiments of the aliphatic polyesters of the present invention. The plasticizers may be present in an amount sufficient to provide the desired characteristics, for example, (a) more effective compatibilization of the melt blend components, (b) improved processing characteristics during the blending and processing steps, and (c) control and regulation of the sensitivity and degradation of the polymer by moisture. Suitable plasticizers include, but are not limited to, derivatives of oligomeric lactic acid, selected from the group defined by the formula:
where R is a hydrogen, alkyl, aryl, alkylaryl, acetyl, heteroatom, or a mixture thereof and R is saturated, where R′ is a hydrogen, alkyl, aryl, alkylaryl, acetyl, heteroatom, or a mixture thereof and R′ is saturated, where R and R′ cannot both be hydrogen, where q is an integer: 2≦q≦75; and mixtures thereof. In certain exemplary embodiments, q is an integer: 2≦q≦10. As used herein, the term “derivatives of oligomeric lactic acid” includes derivatives of oligomeric lactide.
The physical properties of aliphatic polyesters depend on several factors, including, inter alia, the composition of the repeat units, flexibility of the chain, presence of polar groups, molecular mass, degree of branching, crystallinity, and orientation. For example, short-chain branches reduce the degree of crystallinity of polymers while long-chain branches lower the melt viscosity and impart, inter alia, elongational viscosity with tension-stiffening behavior. The properties of the material utilized further can be tailored by blending, and copolymerizing it with another polymer, or by changing the macromolecular architecture (e.g., hyper-branched polymers, star-shaped, or dendrimers, etc.). The properties of any such suitable aliphatic polyesters (e.g., hydrophobicity, hydrophilicity, rate of degradation, etc.) can be tailored by introducing select functional groups along the polymer chains. For example, poly(phenyllactide) will degrade at about ⅕th of the rate of racemic poly(lactide) at a pH of 7.4 at 55° C. One of ordinary skill in the art, with the benefit of this disclosure, will be able to determine the appropriate functional groups to introduce to the polymer chains to achieve the desired physical properties of the aliphatic polyesters.
By way of example and not limitation, certain crosslinked aliphatic polyesters may be prepared via a two-step process that includes polymerizing and/or functionalizing an aliphatic polyester to form a functionalized aliphatic polyester and crosslinking the molecules of the functionalized aliphatic polyester. Examples of processes that may be used to prepare crosslinked aliphatic polyesters that may be suitable for use in embodiments of the present invention are described in an article entitled “Structure Modification and Crosslinking of Methacrylated Polylactide Oligomers” by Antti O. Helminen et al. in The Journal of Applied Polymer Science, Vol. 86, pages 3616-3624 (2002), and WIPO Patent Application Publication No. WO 2006/053936 by Jukka Seppälä, the relevant disclosures of which are herein incorporated by reference.
For example, a degradable aliphatic polyester may be polymerized to include different numbers of hydroxyl functional groups, or an existing aliphatic polyester may be functionalized with different numbers of hydroxyl functional groups, to form a functionalized aliphatic polyester having one or more carbon-carbon double bonds. These functional groups may be provided via reaction of the aliphatic polyester with a functionalizing agent that may comprise one or more diols, polyfunctional alcohols, dicarboxylic acids, polyfunctional carboxylic acids, anhydrides, derivatives thereof, and combinations thereof. The choice of a particular functionalizing agent used may depend on several factors that will be recognized by a person of ordinary skill in the art with the benefit of this disclosure, including, but not limited to, the molecular structure and/or size of the functionalized aliphatic polyester desired. After at least one functionalized aliphatic polyester is generated, a crosslinking initiator and/or energy source may be used to form a radical at the double-bond site, and these radicals formed on different molecules of the functionalized aliphatic polyester may interact with each other so as to form one or more crosslinks between them. The crosslinking initiator may comprise any substance that is capable of forming a radical on the functionalized aliphatic polyester. Examples of suitable crosslinking initiators may include organic peroxy compounds (e.g., diazyl peroxides, peroxy esters, peroxy dicarbonates, monoperoxy carbonates, diperoxy ketals, dialkyl peroxides, sulfonyl peroxides, ketone peroxides, and peroxy carboxylic acids), inorganic peroxides (e.g., hydrogen peroxide, oxygen, ozone, and azo compounds), redox initiators, derivatives thereof, and combinations thereof. Suitable energy sources may comprise a heat source, a light source, a radiation source, and combinations thereof. The energy sources suitable for use in embodiments of the present invention may vary by numerous different properties and settings, including but not limited to, wavelength of light produced, intensity of light produced, amount of heat produced, and the like. In certain embodiments, the light source may comprise an instrument that is capable of emitting blue light (e.g., light having a wavelength of about 400 nm to about 500 nm).
In certain embodiments of the present invention where this method of preparing the crosslinked aliphatic polyester is used, the crosslinking initiator may be formulated to remain inactive until it is “activated” by, among other things, certain conditions in the fluid (e.g., pH, temperature, etc.) and/or contact with some other substance. In some embodiments, the crosslinking initiator may be delayed, for example, by encapsulation with a coating that delays its release until a desired time or place. A degradable polymer or a fatty acid may be used as the coating. The choice of a particular crosslinking initiator and/or energy source will be governed by several considerations that will be recognized by one skilled in the art, including but not limited to the following: the type of functionalized aliphatic polyester included, the molecular weight of the functionalized aliphatic polyester, the pH of the treatment fluid, temperature, and/or the desired time at which to crosslink the aliphatic polyester. The exact type and amount of crosslinking initiator and/or the particular parameters of the energy source used depends upon the specific aliphatic polyester to be crosslinked, formation temperature conditions, and other factors recognized by those individuals skilled in the art, with the benefit of this disclosure.
Optionally, a crosslinking accelerator may be used, inter alia, to increase the rate at which the functionalized aliphatic polyesters form crosslinks. Examples of suitable crosslinking accelerators that may be used include, but are not limited to, metal compounds (e.g., cobalt compounds), organic amines, and the like. The choice of whether to use a crosslinking accelerator, and, if used, the exact type and amount of the crosslinking accelerator is within the ability of those individuals skilled in the art, with the benefit of this disclosure.
In certain embodiments, the solid particles used in the treatment fluids of the present invention may comprise a degradable aliphatic polyester and a hydrated organic or inorganic compound. Examples of such hydrated organic or inorganic compounds include, but are not limited to, sodium acetate trihydrate, L-tartaric acid disodium salt dihydrate, sodium citrate dihydrate, sodium tetraborate decahydrate, sodium hydrogen phosphate heptahydrate, sodium phosphate dodecahydrate, amylose, starch-based hydrophilic polymers, or cellulose-based hydrophilic polymers. In certain exemplary embodiments, the degradable aliphatic polyester is poly(lactic acid). In certain exemplary embodiments, the hydrated organic or inorganic compound is sodium acetate trihydrate. In certain exemplary embodiments, the lactide units of the aliphatic polyester and releasable water from the hydrated organic or inorganic compound may be present in stoichiometric amounts. In certain exemplary embodiments, the bridging agent comprises a degradable aliphatic polyester and a hydrated organic or inorganic compound in combination with a bridging agent that comprises calcium carbonate in an amount in the range of about 1 pound to about 100 pounds of calcium carbonate per barrel of treatment fluid.
In some embodiments, the treatment fluids of the present invention may further comprise a viscosifier. Viscosifiers suitable for use in embodiments of the present invention include, but are not limited to, biopolymers (e.g., xanthan, succinoglycan, and diutan), clarified biolpolymers, cellulose, cellulose derivatives (e.g., hydroxyethylcellulose), guar, and guar derivatives (e.g., hydroxypropyl guar). Commercially available examples of suitable viscosifiers include, but are not limited to, those that are available from Halliburton Energy Services, Inc., of Duncan, Okla., under the trade name “WG-37” and “N-VIS™.” Suitable viscosifiers may also include an organophilic clay, a synthetic oil-soluble polymer, or a polymeric fatty acid. An example of a synthetic oil-soluble polymer is commercially available from Halliburton Energy Services, Inc., of Houston, Tex., under the trade name “BARAPAK®.” An example of a polymeric fatty acid is commercially available from Halliburton Energy Services, Inc., of Houston, Tex., under the trade name “X-VIS™.”
In certain embodiments, a viscosifier should be included in the degradable polymer composition in an amount sufficient to provide a desired degree of solids suspension or viscosity. In some embodiments, a viscosifier may be included in the degradable polymer composition in an amount in the range of about 0.001% to about 2% by volume. In other embodiments, a viscosifier may be included in the degradable polymer composition in an amount in the range of about 0.001% to about 1% by volume.
In some embodiments, the treatment fluids of the present invention may further comprise a fluid loss control additive. Generally, any fluid loss control additive may be suitable for use in the treatment fluids of the present invention. Examples of suitable fluid loss control additives include, but are not limited to, synthetic oil-soluble polymers, powdered hydrocarbon resins, organophilic lignite, starches, starch ether derivatives, hydroxyethylcellulose, cross-linked hydroxyethylcellulose, and combinations thereof. An example of a synthetic oil-soluble polymer is commercially available from Halliburton Energy Services, Inc., of Houston, Tex., under the trade name “BARAPAK®.” In certain exemplary embodiments, the fluid loss control additive may be a synthetic oil-soluble copolymer commercially available from Halliburton Energy Services, Inc., under the trade name “ADAPTA™.”
In some embodiments, the fluid loss control additive may be present in the treatment fluids of the present invention in an amount sufficient to provide a desired degree of fluid loss control. In certain embodiments, the fluid loss control additive may be present in the treatment fluids in an amount in the range of about 0.01% to about 5% by weight. In some embodiments, the fluid loss control additive is present in the subterranean treatment fluid in an amount in the range of about 1% to about 2% by weight.
In accordance with embodiments of the present invention, the treatment fluids of the present invention that comprise a crosslinked aliphatic polyester may be used in any of a variety of suitable applications. By way of example, the crosslinked aliphatic polyesters may be used in subterranean applications, including, but not limited to, drilling, completion, stimulation, and workover operations. Among other things, the crosslinked aliphatic polyesters may be used in subterranean operations as fluid loss control additives, diverting agents, bridging agents, drilling fluid additives, cement additives, and the like. An example method of the present invention generally may comprise providing a treatment fluid comprising a carrier fluid and a solid particle that comprises a crosslinked aliphatic polyester; and introducing the treatment fluid into a well bore having a bottom hole circulating temperature of at least about 300° F. In certain embodiments, the method further may comprise allowing the crosslinked aliphatic polyester to degrade thereby releasing an acid. In certain embodiments, the acid released during hydrolysis of the crosslinked aliphatic polyester may be utilized in a well bore application, such as to facilitate a reduction in viscosity of a fluid or to degrade a filter cake, as well as for numerous other functions in subterranean operations.
Embodiments of the present invention may include using the crosslinked aliphatic polyesters as a bridging agent. An example of a method of the present invention comprises the steps of: placing a treatment fluid in a subterranean formation, the treatment fluid comprising a carrier fluid and a solid particle comprising the aliphatic polyester. The treatment fluid may further comprise a viscosifier and a fluid loss control additive. In certain embodiments, the treatment fluid may be used as a drilling fluid, in that the treatment fluid may be circulated in a well bore while drilling. In certain embodiments, the method may include forming a filter cake comprising the solid particle upon a surface. Fluid loss to the formation through the filter cake may be reduced. As the filter cake comprises the aliphatic polyester, the filter cake may be “self degrading,” in accordance with embodiments of the present invention, in that the filter cake may be removed without assistance of a separate “clean up” solution or “breaker” through the well bore. Though the filter cake formed by the treatment fluids in accordance with embodiments of the present invention may be self degrading, an operator nevertheless occasionally may elect to circulate a separate clean-up solution or breaker through the well bore under certain circumstances, to enhance the rate of degradation of the filter cake. By way of example, removal of the filter cake may be enhanced by contacting the filter cake with water.
Another example of a method of the present invention comprises a method of degrading a filter cake in a subterranean formation, the filter cake having been deposited therein by a treatment fluid comprising a bridging agent, comprising the step of utilizing a bridging agent comprising a degradable material comprising a crosslinked aliphatic polyester. Another example of a method of the present invention comprises a method of drilling an open hole in a subterranean formation, comprising the steps of: circulating through a drill pipe and drill bit a treatment fluid comprising a viscosified fluid, a fluid loss control additive, and a bridging agent comprising a degradable material comprising a crosslinked aliphatic polyester; forming a filter cake comprising the bridging agent upon a surface within the formation; and permitting the filter cake to degrade. The filter cake formed by the treatment fluids of the present invention is removed after a desired amount of time by being contacted with a degrading agent. In certain embodiments, the degrading agent comprises water. The source of the degrading agent may be, inter alia, a treatment fluid, such as a gravel pack fluid or a completion brine, for instance. In certain embodiments, the source of the degrading agent may be the bridging agent itself. For example, the bridging agent may comprise a water-containing compound. Any compound containing releasable water may be used as the water-containing compound. As referred to herein, the term “releasable water” will be understood to mean water that may be released under desired downhole conditions, including, inter alia, temperature. In certain embodiments, the water-containing compound may be sodium acetate trihydrate, sodium borate decahydrate, sodium carbonate decahydrate, or the like. In certain preferred embodiments, the water-containing compound is sodium acetate trihydrate.
Embodiments of the present invention may include using the crosslinked aliphatic polyester as a diverting agent. In one embodiment, the present invention provides a method comprising: providing a treatment fluid; adding to the treatment fluid a diverting agent comprising a solid particle comprising a crosslinked aliphatic polyester; and placing the treatment fluid into a portion of subterranean formation. The solid particle comprising the crosslinked aliphatic polymer may the divert treatment fluids introduced into the treated portion of the subterranean formation.
Embodiments of the present invention may include using the crosslinked aliphatic polyester as a fluid loss control particle. In one embodiment, the present invention provides a method of providing fluid loss control comprising: providing a treatment fluid comprising a carrier fluid and a solid particle comprising a crosslinked aliphatic polyester; and placing the treatment fluid into a well bore that penetrates subterranean formation. The presence of the solid particle comprising the crosslinked aliphatic polyester in the treatment fluid may reduce the loss of fluid from the treatment fluid into the subterranean formation.
Embodiments of the present invention may include using the crosslinked aliphatic polyesters to generate an acid downhole. In one embodiment, the present invention provides a method comprising: providing a treatment fluid that comprises a carrier fluid and a solid particle comprising a crosslinked aliphatic polyester; placing the treatment fluid into a subterranean formation; and allowing an acid to generate from the crosslinked aliphatic polyester. As will be appreciated by those of ordinary skill in the art, with the benefit of this disclosure, the crosslinked aliphatic polyester should undergo degradation and degrade downhole to release an acid. The term “degradation” refers to both the two relatively extreme cases of hydrolytic degradation that the crosslinked aliphatic polyester may undergo, e.g., bulk erosion and surface erosion, and any stage of degradation in between these two. This degradation can be a result of, inter alia, a chemical or thermal reaction, or a reaction induced by radiation.
Embodiments of the present invention may include using the crosslinked aliphatic polyesters to degrade a filter cake. In one embodiment, the present invention provides a method of degrading a filter cake comprising: introducing a treatment fluid that comprises a carrier fluid and a solid particle comprising a crosslinked aliphatic polyester into the subterranean formation; allowing the crosslinked aliphatic polyester to generate an acid; allowing the acid to degrade at least a portion of the filter cake.
Embodiments of the present invention may include using the crosslinked aliphatic polyesters to facilitate a reduction of viscosity of a fluid. In one embodiment, the present invention provides a method comprising: providing a servicing fluid having a viscosity and comprising a carrier fluid and a solid particle comprising a crosslinked aliphatic polyester. In certain embodiments, to provide the servicing fluid with an increased viscosity, the servicing fluid may comprise a gelling agent and/or a crosslinking agent. The method may comprise introducing the servicing fluid into a subterranean formation. The method may comprise allowing the crosslinked aliphatic polyester to release an acid, thereby reducing the viscosity of the servicing fluid. The acid released by the crosslinked aliphatic polyester may reduce the viscosity of the servicing fluid, in certain embodiments, due to a pH reduction. One should note that the conditions of the fluid, e.g., the basicity or acidity of the fluid, will affect the hydrolysis of the crosslinked aliphatic polyester.
Embodiments of the present invention may include using the crosslinked aliphatic polyesters as a cement additive. An example of a method of the present invention is a method that comprises: providing a cement composition that comprises hydraulic cement, a solid particle comprising a crosslinked aliphatic polyester, and water; placing the cement composition in a subterranean formation, allowing the cement composition to set therein. The method may comprise allowing the crosslinked aliphatic polyester to release an acid.
Embodiments of the present invention may include using the crosslinked aliphatic polyester as a biodegradable downhole tool. In one embodiment, the present invention is directed to a disposable downhole tool comprising a crosslinked aliphatic polyester. The biodegradable downhole tool may comprise a plug that is used in a well stimulation/fracturing operation, commonly known as a “frac plug.” A frac plug is a temporary plug that substantially blocks off permeable zones to prevent loss of fluid into those permeable zones or to protect those zones from damage during a well stimulation/fracturing operation. Examples of suitable biodegradable downhole tools are described in U.S. Pat. No. 7,093,664, the entirety of which is hereby incorporated by reference.
Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. In particular, every range of values (of the form, “about a to about b,” or, equivalently, “approximately a to b,” or, equivalently, “approximately a-b”) disclosed herein is to be understood as referring to the power set (the set of all subsets) of the respective range of values, and set forth every range encompassed within the broader range of values. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee.
This application is a continuation-in-part of U.S. patent application Ser. No. 11/634,320, entitled “Improved Treatment Fluids and Methods of Forming Degradable Filter Cakes and Their Use in Subterranean Formations,” filed Dec. 5, 2006 now U.S. Pat. No. 7,674,753, which is a continuation-in-part of U.S. patent application Ser. No. 10/832,163, entitled “Improved Treatment Fluids and Methods of Use in Subterranean Formations,” filed Apr. 26, 2004 now abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 10/664,126 entitled “Improved Subterranean Treatment Fluids and Methods of Treating Subterranean Formations,” filed Sep. 17, 2003, incorporated by reference herein for all purposes, and from which priority is claimed pursuant to 35 U.S.C. §120.
Number | Name | Date | Kind |
---|---|---|---|
2005183 | Flemming | Jun 1935 | A |
2238671 | Woodhouse | Apr 1941 | A |
2703316 | Palmer | Mar 1955 | A |
3173484 | Huitt et al. | Mar 1965 | A |
3195635 | Fast | Jul 1965 | A |
3272650 | MacVittie | Sep 1966 | A |
3302719 | Fischer | Feb 1967 | A |
3364995 | Atkins et al. | Jan 1968 | A |
3366178 | Malone et al. | Jan 1968 | A |
3455390 | Gallus | Jul 1969 | A |
3784585 | Schmitt et al. | Jan 1974 | A |
3819525 | Hattenbrun | Jun 1974 | A |
3828854 | Templeton et al. | Aug 1974 | A |
3836465 | Rhudy et al. | Sep 1974 | A |
3868998 | Lybarger et al. | Mar 1975 | A |
3912692 | Casey et al. | Oct 1975 | A |
3948672 | Harnsberger | Apr 1976 | A |
3955993 | Curtice | May 1976 | A |
3960736 | Free et al. | Jun 1976 | A |
3968840 | Tate | Jul 1976 | A |
3986355 | Klaeger | Oct 1976 | A |
3998272 | Maly | Dec 1976 | A |
3998744 | Arnold et al. | Dec 1976 | A |
4010071 | Colegrove | Mar 1977 | A |
4068718 | Cooke, Jr. et al. | Jan 1978 | A |
4169798 | DeMartino | Oct 1979 | A |
4172066 | Zweigle et al. | Oct 1979 | A |
4261421 | Watanabe | Apr 1981 | A |
4265673 | Pace et al. | May 1981 | A |
4267887 | Watanabe | May 1981 | A |
4299825 | Lee | Nov 1981 | A |
4387769 | Erbstoesser et al. | Jun 1983 | A |
4460052 | Gockel | Jul 1984 | A |
4470915 | Conway | Sep 1984 | A |
4498995 | Gockel | Feb 1985 | A |
4502540 | Byham | Mar 1985 | A |
4506734 | Nolte | Mar 1985 | A |
4521316 | Sikorski | Jun 1985 | A |
4526695 | Erbstoesser et al. | Jul 1985 | A |
4632876 | Laird et al. | Dec 1986 | A |
4694905 | Armbruster | Sep 1987 | A |
4715967 | Bellis | Dec 1987 | A |
4716964 | Erbstoesser et al. | Jan 1988 | A |
4767706 | Levesque | Aug 1988 | A |
4772346 | Anderson et al. | Sep 1988 | A |
4785884 | Armbruster | Nov 1988 | A |
4793416 | Mitchell | Dec 1988 | A |
4797262 | Dewitz | Jan 1989 | A |
4809783 | Hollenbeck et al. | Mar 1989 | A |
4817721 | Pober | Apr 1989 | A |
4822500 | Dobson, Jr. et al. | Apr 1989 | A |
4829100 | Murphey et al. | May 1989 | A |
4836940 | Alexander | Jun 1989 | A |
4843118 | Lai et al. | Jun 1989 | A |
4848467 | Cantu et al. | Jul 1989 | A |
4863980 | Cowan et al. | Sep 1989 | A |
4886354 | Welch et al. | Dec 1989 | A |
4894231 | Moreau et al. | Jan 1990 | A |
4957165 | Cantu et al. | Sep 1990 | A |
4961466 | Himes et al. | Oct 1990 | A |
4986353 | Clark et al. | Jan 1991 | A |
4986354 | Cantu et al. | Jan 1991 | A |
4986355 | Casad et al. | Jan 1991 | A |
5034139 | Reid et al. | Jul 1991 | A |
5082056 | Tackett, Jr. | Jan 1992 | A |
5142023 | Gruber et al. | Aug 1992 | A |
5152781 | Tang et al. | Oct 1992 | A |
5161615 | Hutchins et al. | Nov 1992 | A |
5203834 | Hutchins et al. | Apr 1993 | A |
5213446 | Dovan | May 1993 | A |
5216050 | Sinclair | Jun 1993 | A |
5247059 | Gruber et al. | Sep 1993 | A |
5249628 | Surjaatmadja | Oct 1993 | A |
5251697 | Shuler | Oct 1993 | A |
5295542 | Cole et al. | Mar 1994 | A |
5304620 | Holtmyer et al. | Apr 1994 | A |
5314031 | Hale et al. | May 1994 | A |
5325923 | Surjaatmadja et al. | Jul 1994 | A |
5330005 | Card et al. | Jul 1994 | A |
5359026 | Gruber | Oct 1994 | A |
5360068 | Sprunt et al. | Nov 1994 | A |
5363916 | Himes et al. | Nov 1994 | A |
5373901 | Norman et al. | Dec 1994 | A |
5386874 | Laramay et al. | Feb 1995 | A |
5396957 | Surjaatmadja et al. | Mar 1995 | A |
5402846 | Jennings, Jr. et al. | Apr 1995 | A |
5439055 | Card et al. | Aug 1995 | A |
5460226 | Lawton et al. | Oct 1995 | A |
5464060 | Hale et al. | Nov 1995 | A |
5475080 | Gruber et al. | Dec 1995 | A |
5484881 | Gruber et al. | Jan 1996 | A |
5487897 | Polson et al. | Jan 1996 | A |
5492177 | Yeh et al. | Feb 1996 | A |
5496557 | Feijen et al. | Mar 1996 | A |
5497830 | Boles et al. | Mar 1996 | A |
5499678 | Surjaatmadja et al. | Mar 1996 | A |
5501276 | Weaver et al. | Mar 1996 | A |
5505787 | Yamaguchi | Apr 1996 | A |
5512071 | Yam et al. | Apr 1996 | A |
5536807 | Gruber et al. | Jul 1996 | A |
5555936 | Pirri et al. | Sep 1996 | A |
5566310 | Chan | Oct 1996 | A |
5591700 | Harris et al. | Jan 1997 | A |
5594095 | Gruber et al. | Jan 1997 | A |
5602083 | Gabrysch et al. | Feb 1997 | A |
5604186 | Hunt et al. | Feb 1997 | A |
5607905 | Dobson, Jr. et al. | Mar 1997 | A |
5613558 | Dillenbeck | Mar 1997 | A |
5670473 | Scepanski | Sep 1997 | A |
5697440 | Weaver et al. | Dec 1997 | A |
5698322 | Tsai et al. | Dec 1997 | A |
5723416 | Liao | Mar 1998 | A |
5765642 | Surjaatmadja | Jun 1998 | A |
5783527 | Dobson, Jr. et al. | Jul 1998 | A |
5791415 | Nguyen et al. | Aug 1998 | A |
5799734 | Normal et al. | Sep 1998 | A |
5833000 | Weaver et al. | Nov 1998 | A |
5849401 | El-Afandi et al. | Dec 1998 | A |
5853048 | Weaver et al. | Dec 1998 | A |
5888944 | Patel | Mar 1999 | A |
5893416 | Read | Apr 1999 | A |
5908073 | Nguyen et al. | Jun 1999 | A |
5916849 | House | Jun 1999 | A |
5924488 | Nguyen et al. | Jul 1999 | A |
5964291 | Bourne et al. | Oct 1999 | A |
5977030 | House | Nov 1999 | A |
5979557 | Card et al. | Nov 1999 | A |
5981447 | Chang | Nov 1999 | A |
5996693 | Heathman | Dec 1999 | A |
6004400 | Bishop et al. | Dec 1999 | A |
6024170 | McCabe et al. | Feb 2000 | A |
6028113 | Scepanski | Feb 2000 | A |
6047772 | Weaver et al. | Apr 2000 | A |
6110875 | Tjon-Joe-Pin et al. | Aug 2000 | A |
6114410 | Betzold | Sep 2000 | A |
6123159 | Brookey et al. | Sep 2000 | A |
6123965 | Jacob et al. | Sep 2000 | A |
6131661 | Conner et al. | Oct 2000 | A |
6135987 | Tsai et al. | Oct 2000 | A |
6143698 | Murphey et al. | Nov 2000 | A |
6148917 | Brookey et al. | Nov 2000 | A |
6162766 | Muir et al. | Dec 2000 | A |
6169058 | Le et al. | Jan 2001 | B1 |
6172011 | Card et al. | Jan 2001 | B1 |
6189615 | Sydansk | Feb 2001 | B1 |
6202751 | Chatterji et al. | Mar 2001 | B1 |
6209643 | Nguyen et al. | Apr 2001 | B1 |
6209646 | Reddy et al. | Apr 2001 | B1 |
6214773 | Harris et al. | Apr 2001 | B1 |
6242390 | Mitchell et al. | Jun 2001 | B1 |
6258755 | House | Jul 2001 | B1 |
6260622 | Blok et al. | Jul 2001 | B1 |
6291013 | Gibson et al. | Sep 2001 | B1 |
6300286 | Dobson, Jr. et al. | Oct 2001 | B1 |
6302209 | Thompson et al. | Oct 2001 | B1 |
6308788 | Patel et al. | Oct 2001 | B1 |
6311773 | Todd et al. | Nov 2001 | B1 |
6323307 | Bigg et al. | Nov 2001 | B1 |
6326458 | Gruber et al. | Dec 2001 | B1 |
6328105 | Betzold | Dec 2001 | B1 |
6330917 | Chatterji et al. | Dec 2001 | B2 |
6357527 | Norman et al. | Mar 2002 | B1 |
6364945 | Chatterji et al. | Apr 2002 | B1 |
6380138 | Ischy et al. | Apr 2002 | B1 |
6387986 | Moradi-Araghi et al. | May 2002 | B1 |
6390195 | Nguyen et al. | May 2002 | B1 |
6394185 | Constien | May 2002 | B1 |
6422314 | Todd et al. | Jul 2002 | B1 |
6422326 | Brookey et al. | Jul 2002 | B1 |
6432155 | Swazey et al. | Aug 2002 | B1 |
6454003 | Chang et al. | Sep 2002 | B1 |
6485947 | Rajgarhia et al. | Nov 2002 | B1 |
6488763 | Brothers et al. | Dec 2002 | B2 |
6494263 | Todd | Dec 2002 | B2 |
6508305 | Brannon et al. | Jan 2003 | B1 |
6509301 | Vollmer et al. | Jan 2003 | B1 |
6527051 | Reddy et al. | Mar 2003 | B1 |
6554071 | Reddy et al. | Apr 2003 | B1 |
6566310 | Chan | May 2003 | B2 |
6569814 | Brady et al. | May 2003 | B1 |
6578630 | Simpson et al. | Jun 2003 | B2 |
6586372 | Bradbury | Jul 2003 | B1 |
6599863 | Palmer et al. | Jul 2003 | B1 |
6667279 | Hessert et al. | Dec 2003 | B1 |
6669771 | Tokiwa et al. | Dec 2003 | B2 |
6681856 | Chatterji et al. | Jan 2004 | B1 |
6686328 | Binder | Feb 2004 | B1 |
6691780 | Nguyen et al. | Feb 2004 | B2 |
6702023 | Harris et al. | Mar 2004 | B1 |
6702044 | Reddy | Mar 2004 | B2 |
6710019 | Sawdon et al. | Mar 2004 | B1 |
6716797 | Brookey | Apr 2004 | B2 |
6737385 | Todd et al. | May 2004 | B2 |
6761218 | Nguyen et al. | Jul 2004 | B2 |
6763888 | Harris et al. | Jul 2004 | B1 |
6764981 | Eoff et al. | Jul 2004 | B1 |
6770293 | Angel et al. | Aug 2004 | B2 |
6793018 | Dawson et al. | Sep 2004 | B2 |
6793730 | Reddy et al. | Sep 2004 | B2 |
6806235 | Mueller et al. | Oct 2004 | B1 |
6817414 | Lee | Nov 2004 | B2 |
6818594 | Freeman et al. | Nov 2004 | B1 |
6828280 | England et al. | Dec 2004 | B2 |
6837309 | Boney et al. | Jan 2005 | B2 |
6840318 | Lee et al. | Jan 2005 | B2 |
6852173 | Banerjee et al. | Feb 2005 | B2 |
6861394 | Ballard et al. | Mar 2005 | B2 |
6877563 | Todd et al. | Apr 2005 | B2 |
6883608 | Parlar et al. | Apr 2005 | B2 |
6886635 | Hossaini et al. | May 2005 | B2 |
6896058 | Munoz, Jr. et al. | May 2005 | B2 |
6904971 | Brothers et al. | Jun 2005 | B2 |
6949491 | Cooke, Jr. | Sep 2005 | B2 |
6953090 | Vijn et al. | Oct 2005 | B2 |
6959767 | Horton et al. | Nov 2005 | B2 |
6978838 | Parlar et al. | Dec 2005 | B2 |
6981552 | Reddy et al. | Jan 2006 | B2 |
6983798 | Todd | Jan 2006 | B2 |
6983801 | Dawson et al. | Jan 2006 | B2 |
6987083 | Phillippi et al. | Jan 2006 | B2 |
6997259 | Nguyen | Feb 2006 | B2 |
7000701 | Todd et al. | Feb 2006 | B2 |
7007752 | Reddy et al. | Mar 2006 | B2 |
7021377 | Todd et al. | Apr 2006 | B2 |
7032663 | Nguyen | Apr 2006 | B2 |
7033976 | Guzman | Apr 2006 | B2 |
7036586 | Roddy et al. | May 2006 | B2 |
7036587 | Munoz, Jr. et al. | May 2006 | B2 |
7044220 | Nguyen et al. | May 2006 | B2 |
7044224 | Nguyen | May 2006 | B2 |
7049272 | Sinclair et al. | May 2006 | B2 |
7063151 | Nguyen et al. | Jun 2006 | B2 |
7066258 | Justus et al. | Jun 2006 | B2 |
7066260 | Sullivan et al. | Jun 2006 | B2 |
7069994 | Cooke, Jr. | Jul 2006 | B2 |
7080688 | Todd et al. | Jul 2006 | B2 |
7093658 | Chatterji et al. | Aug 2006 | B2 |
7093664 | Todd et al. | Aug 2006 | B2 |
7096947 | Todd et al. | Aug 2006 | B2 |
7101829 | Guichard et al. | Sep 2006 | B2 |
7131491 | Blauch et al. | Nov 2006 | B2 |
7132389 | Lee | Nov 2006 | B2 |
7140438 | Frost et al. | Nov 2006 | B2 |
7147067 | Getzlaf et al. | Dec 2006 | B2 |
7151077 | Prud'homme et al. | Dec 2006 | B2 |
7153902 | Altes et al. | Dec 2006 | B2 |
7156174 | Roddy et al. | Jan 2007 | B2 |
7165617 | Lord et al. | Jan 2007 | B2 |
7166560 | Still et al. | Jan 2007 | B2 |
7168489 | Frost et al. | Jan 2007 | B2 |
7172022 | Reddy et al. | Feb 2007 | B2 |
7178594 | Patel | Feb 2007 | B2 |
7178596 | Blauch et al. | Feb 2007 | B2 |
7195068 | Todd | Mar 2007 | B2 |
7204311 | Welton et al. | Apr 2007 | B2 |
7204312 | Roddy et al. | Apr 2007 | B2 |
7205264 | Boles | Apr 2007 | B2 |
7216705 | Saini et al. | May 2007 | B2 |
7219731 | Sullivan | May 2007 | B2 |
7228904 | Todd et al. | Jun 2007 | B2 |
7256159 | Guichard et al. | Aug 2007 | B2 |
7261156 | Nguyen et al. | Aug 2007 | B2 |
7264051 | Nguyen et al. | Sep 2007 | B2 |
7265079 | Wilbert et al. | Sep 2007 | B2 |
7267170 | Mang et al. | Sep 2007 | B2 |
7276466 | Todd et al. | Oct 2007 | B2 |
7299869 | Kalman | Nov 2007 | B2 |
7299876 | Lord et al. | Nov 2007 | B2 |
7303014 | Reddy et al. | Dec 2007 | B2 |
7306037 | Nguyen et al. | Dec 2007 | B2 |
7322412 | Badalamenti et al. | Jan 2008 | B2 |
7353876 | Savery et al. | Apr 2008 | B2 |
7353879 | Todd et al. | Apr 2008 | B2 |
7413017 | Nguyen et al. | Aug 2008 | B2 |
7419937 | Rimmer et al. | Sep 2008 | B2 |
7448450 | Luke et al. | Nov 2008 | B2 |
7455112 | Moorehead et al. | Nov 2008 | B2 |
7461697 | Todd et al. | Dec 2008 | B2 |
7475728 | Pauls et al. | Jan 2009 | B2 |
7476644 | Cooke, Jr. | Jan 2009 | B2 |
7484564 | Welton et al. | Feb 2009 | B2 |
7497258 | Savery et al. | Mar 2009 | B2 |
7497278 | Schriener et al. | Mar 2009 | B2 |
7501530 | Todd et al. | Mar 2009 | B2 |
7506689 | Surjaatmadja et al. | Mar 2009 | B2 |
7547665 | Welton et al. | Jun 2009 | B2 |
7553800 | Munoz, Jr. et al. | Jun 2009 | B2 |
7595280 | Welton et al. | Sep 2009 | B2 |
7598208 | Todd | Oct 2009 | B2 |
7608566 | Saini et al. | Oct 2009 | B2 |
7608567 | Saini | Oct 2009 | B2 |
7648946 | Munoz | Jan 2010 | B2 |
7662753 | Saini | Feb 2010 | B2 |
20010016562 | Muir et al. | Aug 2001 | A1 |
20020036088 | Todd | Mar 2002 | A1 |
20020119169 | Angel | Aug 2002 | A1 |
20020125012 | Dawson | Sep 2002 | A1 |
20030054962 | England | Mar 2003 | A1 |
20030060374 | Cooke | Mar 2003 | A1 |
20030114314 | Ballard | Jun 2003 | A1 |
20030130133 | Vollmer | Jul 2003 | A1 |
20030147965 | Bassett et al. | Aug 2003 | A1 |
20030188766 | Banerjee | Oct 2003 | A1 |
20030230407 | Vijn et al. | Dec 2003 | A1 |
20030234103 | Lee | Dec 2003 | A1 |
20040014606 | Parlar | Jan 2004 | A1 |
20040014607 | Sinclair | Jan 2004 | A1 |
20040040706 | Hossaini | Mar 2004 | A1 |
20040055747 | Lee | Mar 2004 | A1 |
20040070093 | Mathiowitz et al. | Apr 2004 | A1 |
20040094300 | Sullivan | May 2004 | A1 |
20040099416 | Vijn | May 2004 | A1 |
20040106525 | Wilbert | Jun 2004 | A1 |
20040138068 | Rimmer | Jul 2004 | A1 |
20040152601 | Still | Aug 2004 | A1 |
20040152602 | Boles | Aug 2004 | A1 |
20040162386 | Altes | Aug 2004 | A1 |
20040170836 | Bond et al. | Sep 2004 | A1 |
20040214724 | Todd | Oct 2004 | A1 |
20040216876 | Lee | Nov 2004 | A1 |
20040231845 | Cooke, Jr. | Nov 2004 | A1 |
20040261993 | Nguyen | Dec 2004 | A1 |
20040261995 | Nguyen | Dec 2004 | A1 |
20040261996 | Munoz | Dec 2004 | A1 |
20040261999 | Nguyen | Dec 2004 | A1 |
20050006095 | Justus | Jan 2005 | A1 |
20050028976 | Nguyen | Feb 2005 | A1 |
20050034861 | Saini et al. | Feb 2005 | A1 |
20050034865 | Todd | Feb 2005 | A1 |
20050034868 | Frost | Feb 2005 | A1 |
20050045328 | Frost | Mar 2005 | A1 |
20050051330 | Nguyen | Mar 2005 | A1 |
20050056423 | Todd | Mar 2005 | A1 |
20050059556 | Munoz, Jr. et al. | Mar 2005 | A1 |
20050059557 | Todd et al. | Mar 2005 | A1 |
20050059558 | Blanch | Mar 2005 | A1 |
20050103496 | Todd | May 2005 | A1 |
20050126780 | Todd | Jun 2005 | A1 |
20050126785 | Todd | Jun 2005 | A1 |
20050130848 | Todd et al. | Jun 2005 | A1 |
20050161220 | Todd | Jul 2005 | A1 |
20050167104 | Roddy | Aug 2005 | A1 |
20050167105 | Roddy | Aug 2005 | A1 |
20050167107 | Roddy | Aug 2005 | A1 |
20050183741 | Surjaatmadja et al. | Aug 2005 | A1 |
20050205258 | Reddy | Sep 2005 | A1 |
20050205265 | Todd | Sep 2005 | A1 |
20050205266 | Todd | Sep 2005 | A1 |
20050252659 | Sullivan | Nov 2005 | A1 |
20050272613 | Cooke | Dec 2005 | A1 |
20050277554 | Blauch et al. | Dec 2005 | A1 |
20060016596 | Pauls | Jan 2006 | A1 |
20060032633 | Nguyen | Feb 2006 | A1 |
20060046938 | Harris et al. | Mar 2006 | A1 |
20060048938 | Kalman | Mar 2006 | A1 |
20060065397 | Nguyen | Mar 2006 | A1 |
20060105917 | Munoz | May 2006 | A1 |
20060105918 | Munoz, Jr. et al. | May 2006 | A1 |
20060108150 | Luke | May 2006 | A1 |
20060118300 | Welton et al. | Jun 2006 | A1 |
20060169182 | Todd et al. | Aug 2006 | A1 |
20060169183 | Todd | Aug 2006 | A1 |
20060169448 | Savery et al. | Aug 2006 | A1 |
20060169450 | Mang et al. | Aug 2006 | A1 |
20060169452 | Savery et al. | Aug 2006 | A1 |
20060169453 | Savery et al. | Aug 2006 | A1 |
20060172891 | Todd | Aug 2006 | A1 |
20060172893 | Todd et al. | Aug 2006 | A1 |
20060172894 | Mang et al. | Aug 2006 | A1 |
20060172895 | Mang et al. | Aug 2006 | A1 |
20060185847 | Saini | Aug 2006 | A1 |
20060185848 | Surjaatmadja | Aug 2006 | A1 |
20060205608 | Todd | Sep 2006 | A1 |
20060234873 | Ballard | Oct 2006 | A1 |
20060243449 | Welton et al. | Nov 2006 | A1 |
20060247135 | Welton | Nov 2006 | A1 |
20060254774 | Saini et al. | Nov 2006 | A1 |
20060258543 | Saini | Nov 2006 | A1 |
20060258544 | Saini | Nov 2006 | A1 |
20060276345 | Todd et al. | Dec 2006 | A1 |
20060283597 | Schriener | Dec 2006 | A1 |
20070042912 | Welton et al. | Feb 2007 | A1 |
20070049501 | Saini et al. | Mar 2007 | A1 |
20070066492 | Funkhouser et al. | Mar 2007 | A1 |
20070066493 | Funkhouser et al. | Mar 2007 | A1 |
20070078063 | Munoz | Apr 2007 | A1 |
20070078064 | Munoz et al. | Apr 2007 | A1 |
20070100029 | Reddy et al. | May 2007 | A1 |
20070235190 | Lord | Oct 2007 | A1 |
20070238623 | Saini et al. | Oct 2007 | A1 |
20070281868 | Pauls et al. | Dec 2007 | A1 |
20070298977 | Mang et al. | Dec 2007 | A1 |
20080009423 | Mang et al. | Jan 2008 | A1 |
20080026955 | Munoz et al. | Jan 2008 | A1 |
20080026959 | Munoz et al. | Jan 2008 | A1 |
20080026960 | Munoz et al. | Jan 2008 | A1 |
20080027157 | Munoz et al. | Jan 2008 | A1 |
20080070810 | Mang et al. | Mar 2008 | A1 |
20080139415 | Todd et al. | Jun 2008 | A1 |
20080169102 | Carbajal et al. | Jul 2008 | A1 |
20090062157 | Munoz et al. | Mar 2009 | A1 |
20090258798 | Munoz | Oct 2009 | A1 |
Number | Date | Country |
---|---|---|
0 510 762 | Oct 1992 | EP |
0 879 935 | Nov 1998 | EP |
0 879 935 | Feb 1999 | EP |
1 413 710 | Apr 2004 | EP |
2 412 389 | Mar 2004 | GB |
2004181820 | Jul 2004 | JP |
WO 9315127 | Aug 1993 | WO |
WO 9407949 | Apr 1994 | WO |
WO 9408078 | Apr 1994 | WO |
WO 9408090 | Apr 1994 | WO |
WO 9509879 | Apr 1995 | WO |
WO 9711845 | Apr 1997 | WO |
WO 9927229 | Jun 1999 | WO |
WO 0057022 | Sep 2000 | WO |
WO 0102698 | Jan 2001 | WO |
WO 0187797 | Nov 2001 | WO |
WO 0194744 | Dec 2001 | WO |
WO 0255843 | Jan 2002 | WO |
WO 0212674 | Feb 2002 | WO |
WO 03027431 | Apr 2003 | WO |
WO 03027431 | Apr 2003 | WO |
WO 2004007905 | Jan 2004 | WO |
WO 2004037946 | May 2004 | WO |
WO 2004038176 | May 2004 | WO |
06053936 | May 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20090258798 A1 | Oct 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11634320 | Dec 2006 | US |
Child | 12456538 | US | |
Parent | 10832163 | Apr 2004 | US |
Child | 11634320 | US | |
Parent | 10664126 | Sep 2003 | US |
Child | 10832163 | US |